CorEvitas is a science-led, real-world data intelligence company. Using data from syndicated registries, bespoke longitudinal research, patient experience and EMR to understand the comparative effectiveness and safety of approved therapies, CorEvitas provides biopharmaceutical companies with objective data and clinical insights to demonstrate product value to clinicians, patients, payers, and regulators.

Our leading suite of innovative, real-world evidence services utilize US retinal EMR and US claims data, as well as European & UK primary and secondary care datasets. These resources allow us to provide a range of health utilization analytics, market insight and market access reports as well as comparator studies across multiple markets.

Our teams provide scientific rigor across the entire strategic process - applying insight and recommendations across ideation, design, implementation, and communication. This ensures that we produce both reliable and compelling evidence that drives submissions and evidence arguments. From determining the best research methodology, to defining the most useful endpoints, our team provides an agile approach whilst applying the highest standards of scientific and academic practice.

Our team, which includes clinicians and physicians, have cross-functional expertise, bringing together expansive in-house experience in:
  • Retrospective analysis of real-world data (RWD)
  • Health economics and outcomes research
  • Market access
  • Medical affairs
  • Epidemiology


Get Involved 

To Sponsor Or Exhibit

David Boore
+44 20 8164 3052

To Speak

Francesca Wiggins

Marketing Opportunities

Diana Cobzac